|
|
|
Volumn 28, Issue 4, 2008, Pages 639-641
|
|
Inhibitory effect of sorafenib combined with arsenic trioxide on hepatocellular carcinoma cells
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARSENIC TRIOXIDE;
BENZENESULFONIC ACID DERIVATIVE;
MITOGEN ACTIVATED PROTEIN KINASE;
ORGANOARSENIC DERIVATIVE;
OXIDE;
PYRIDINE DERIVATIVE;
SORAFENIB;
APOPTOSIS;
ARTICLE;
CELL PROLIFERATION;
CELL SURVIVAL;
DRUG EFFECT;
DRUG POTENTIATION;
FLOW CYTOMETRY;
HUMAN;
LIVER CELL CARCINOMA;
LIVER TUMOR;
METABOLISM;
MITOCHONDRIAL MEMBRANE POTENTIAL;
PATHOLOGY;
TUMOR CELL LINE;
WESTERN BLOTTING;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
ARSENICALS;
BENZENESULFONATES;
BLOTTING, WESTERN;
CARCINOMA, HEPATOCELLULAR;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CELL SURVIVAL;
DRUG SYNERGISM;
EXTRACELLULAR SIGNAL-REGULATED MAP KINASES;
FLOW CYTOMETRY;
HUMANS;
LIVER NEOPLASMS;
MEMBRANE POTENTIAL, MITOCHONDRIAL;
OXIDES;
PYRIDINES;
|
|
EID: 63149135554
PISSN: 16734254
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
